The objectives of this study were to identify filarial antigens which induce enhanced clearance of circulating microfilariae and to establish if human antibody reactivity with these molecules correlates with the apparent parasite burdens of residents of an endemic area of Bancroftian filariasis. Mice immunized with an extract of Brugia malayi microfilariae develop IgG antibodies to four major filarial antigens with an apparent molecular weight (Mr) of -112,000, 60,000, 45,000, and 25,000. Animals immunized with gel slices containing the -25,000-M, antigen are resistant to intravenous challenge with live microfilariae (78-98% reduction in parasitemia vs. controls, P < 0.01). A group of 22 amicrofilaremic humans had a significantly higher (P < 0.025) mean antibody titer to the M, 25,000-M, antigen (1: 424) than 16 microfilaremic individuals (1:95). There were no significant differences between the two groups in antibody titers to filarial antigens of M, -112,000, 60,000, and 45,000 Mr.
Introduction
More than 90 million people inhabiting tropical areas of the world are infected with the helminths Wuchereria bancrofli and Brugia malayi (1) . Infection of the human host by third-stage larvae (L3)' is initiated through the bites of several types of mosquitoes, including Anopheles, Aedes, Culex, and Mansonia species. The larvae mature within several months into lymphaticdwelling adult parasites which release microfilariae (mf) that can be detected in the bloodstream. The level of blood-borne mf is crucial to humoral immune reactions to filarial antigens, ranging from an apparent lack of lymphocyte proliferative responsiveness to a marked degree of lymphoid reactivity and high levels of serum anti-mf antibodies (2-4). These differences in immune reactivity correlate, in general, with the level of microfilaremia in the human host (5, 6 (7) .
Strategies to control the spread of filariasis have included administration of antifilarial drugs and the decrease of the vector population with insecticides. As these measures have had only limited success in most endemic areas, immunologic approaches such as vaccines have been proposed. A moderate degree of resistance to infection (manifest by reductions in adult worm load and number of circulating mf) can be elicited by administration of attenuated Brugia spp to dogs and monkeys (8, 9) . Other models of animal filariasis also indicate that protective responses can be induced by exposure to live or irradiated organisms (10, 1 1) . The specific protective antigens contained in these complex parasite preparations have not been biochemically defined or immunologically characterized in experimental animals or humans with filariasis. Utilizing jirds (rodent Mongolian gerbils; Meriones unguiculatus) subcutaneously challenged with L3, the natural route of infection in humans, we have recently shown that administration of a crude extract of B. malayi mf induces a 50% reduction in adult worm load and >80% decrease in the intensity of microfilaremia compared with control animals ( 12). This moderate degree ofresistance was associated with the development ofjird antibodies to major mf antigens having apparent molecular weights (Mr) of -150,000, 75,000, 42,000, and 25,000; several ofthese antigens were also detected in extracts of immature and mature adult filariae. Immunization of mice with the same antigen preparation also decreased the number of blood-borne mf in these experimental hosts by an antibodydependent mechanism (13). The present study was designed to identify the specific component(s) of the parasite preparation that induce a reduction in microfilaremia and to examine the antibody response to these antigens in clinically and parasitologically characterized groups of humans with W bancrofti infection. Our results indicate that a mf antigen of -25,000 Mr induces a significantly higher rate ofclearance of microfilaremia in mice compared with the three other major antigens of M, 112,000, 60,000, and 45,000 Mr. In humans, the serum antibody titer to the 25,000-M, antigen is significantly higher in amicrofilaremic individuals with low Gib 13 antigen indices (an independent measure ofparasite load) than in microfilaremic subjects matched for age and disease status. In contrast, there were no differences between these two groups of infected subjects in antibody titers to the 1 12,000, 60,000, and 45,000Mr mfantigens. lymphatic filariasis is associated with a parasitologic status that is least conducive to continued transmission of infection.
Methods
Antigen extracts. Jirds infected intraperitoneally with L3 of B. malayi were obtained from J. McCall, University of Georgia, Athens (National Institutes of Health Contract No. 73262). Mf were collected by lavage ofthe peritoneal cavities of 1 2-20-wk-infected jirds. The organisms were washed four times with phosphate-buffered saline (PBS, pH 7.0), frozen, and lyophilized. Soluble material was extracted into PBS at 4°C for 24 h and centrifuged at 20,000 g for 30 min (13); the protein concentration of the resulting supernatant was then determined (14) . In some experiments, parasites were homogenized and proteins solubilized in the presence of the protease inhibitors 2 mM phenylmethylsulfonyl fluoride, 2 mM tosyl-lysine chloromethyl ketone, and 2 mM iodoacetamide (Sigma Chemical Co., St. Louis, MO). L3 were dissected from Aedes aegypti (performed at TRS Laboratories, Athens, GA), washed, sonicated, and proteins were extracted into PBS containing 0.1% Triton X 100 (Sigma Chemical Co.) (15). Immature (<4 wk after the L3 stage) and mature adult B. malayi (males and females) were obtained from the peritoneal cavities ofjirds, and extracts prepared as described for mf.
Sources and measurements of anti-filarial antibodies. Serum containing IgG antibodies capable of conferring protection against the mf stage ofB. malayi was obtained from 18-20-g female CFl mice (Carworth Farms, New City, NY) injected subcutaneously with 10 ,g mf antigen extract 2 and 4 wk earlier (13). Adult female New Zealand white rabbits were immunized biweekly with 100 MAg mf antigen extract in complete Freund's adjuvant (Gibco, Grand Island, NY); serum was obtained 2 wk after the last of three immunizations. Sera of W. bancrofti-infected humans were collected from a study population in Papua New Guinea, as described below. Six Papua New Guineans who live in a region of the country where filariasis is not transmitted served as control serum donors.
Antibodies against B. malayi mf in sera of immunized mice and rabbits were measured by enzyme-linked immunosorbent assay (ELISA) (16). Mfantigen extract (1.0,ug in 0.9% NaCI) was adsorbed to microtiter wells (Becton-Dickinson & Co., Oxnard, CA) and washed twice with PBS containing 0.05% Tween 20 (Sigma Chemical Co.) (PBS/T). Re To examine the stage-specificity of anti-mf antibodies, extracts of L3 (100 Mg), immature adult and mature adult worms (60 Mg each) were subjected to SDS-PAGE, transblotted, and probed with a 1:20 dilution of immune or normal mouse serum. Radioautographs were developed and the relative molecular weight of antigens from each the parasite stages were compared with those detected in mfextract (60 Mg) prepared at the same time.
Identification ofprotective antigens. The ability of the various mf antigens detected by Western blotting to induce protection in mice was compared. Gel segments (1 mm in length and 6 mm wide) corresponding to antigens detected by Western blots with immune mouse serum were cut out from 12 lanes loaded with 30 Mg mf extract each. Gel fragments were then macerated with mortar and pestle and suspended in PBS to a volume of 1.2 ml. Each animal in groups of six female 18-20-g CF1 mice was injected intraperitoneally with 0.2 ml gel suspension; controls were given material from an area of the gel not containing detectable mf antigens. The injections were repeated in 2 wk and the animals challenged intravenously with I05 live mf 2 wk later. The level and duration of microfilaremia were determined as previously described (22) .
Human study population. Antibody titers to specific mf antigens in a group of 22 amicrofilaremic subjects were compared with those of 16 microfilaremic humans. Sera were obtained from 38 villagers born and living in an area of Papua New Guinea endemic for bancroftian filariasis (23) . Demographic information (age, sex, household), history, and pertinent physical examinations of donors were done according to World Health Organization recommendations (24) and with the prior approval ofthe Papua New Guinea government and Human Investigations Committee of University Hospital, Case Western Reserve University. The level of microfilaremia was determined by the nuclepore filtration technique from a 4-ml sample of blood drawn between 2,200 and 2,400 h (25). The level of circulating Gib 13 antigen was used to estimate the relative load of adult worms in the two study groups (26) (27) (28) . Immulon I wells (Dynatech Laboratories) were coated with 50 Ml (10 mg/ml) of a 50% NH4S04 precipitate of Gib 13 ascites fluid (kindly provided by Dr. G. Mitchell, Walter and Eliza Hall Institute, Melbourne, Australia), redissolved in PBS, and the assay was performed with a 1:2 dilution of serum as described by Forsyth et al. (28) . Detection of the level of Gib 13 epitope in serum was expressed as an antigen index (AI) using the formula: AI = cpm bound with test serum/mean cpm bound with pool of five control sera. An AI of .2 was considered to indicate the presence of adult parasites (28) .
To examine whether the amount of Gib 13 antigen detected in our assay might be quantitatively related to the adult worm burden, increasing numbers of immature or mature adult male or female B. malayi were incubated in vitro and the amount of Gib 13 released into the medium measured. 10, 30, and 60 living immature adult female or male B. malayi (removed from the peritoneal cavities of jirds 1 d previously) were incubated for 22 h in 2 ml RPMI 1640 (Gibco) containing 100 U penicillin and 100 ,ug streptomycin per ml at 37°C in 5% CO2 and air. Similar incubations were done with 10 and 40 sexually mature adult male and female worms. The Gib 13 levels of triplicate 50-M1 samples ofthe serumfree supernatants and control medium not exposed to live parasites were then measured and the AI calculated as described above. Worm viability after 22 h incubation was 100%, as judged by motility at 370C.
Human antibodies to mfantigens. In studies with human sera, the antibody titers to microfilarial antigens of specific relative molecular weight were measured and compared. Multiple strips of nitrocellulose paper containing equivalent amounts of transferred mf extract (30 gg applied to each gel lane) were prepared. 2-mm lengths ofpaper containing the antigen of interest (located by the calculated Rf value, i.e., protein migration distance divided by the dye front distance) were then cut out and duplicate samples placed in 2 ml of immune or control human serum samples diluted 1:100 to 1:10,000 in PBS with 5% milk. After 3-h incubation at 25°C, the diluted sera were removed, the paper was washed three times with excess PBS/5% milk, and bound antibodies were detected by immersion in 5 X l10 cpm '251-protein A per milliliter for 2 h. Individual samples ofpaper with attached antigen and associated antibodies were then washed extensively in PBS and radioactivity measured by gamma spectrometry (29-31). The antibody titer to a specific relative molecular weight parasite antigen was defined as the highest dilution of serum which resulted in a mean cpm of bound 1251-protein A > two standard deviations above the mean value for similar dilutions of six control sera. In preliminary studies using a pool of sera from six individuals with bancroftian filariasis, it was established that there was a linear relationship between cpm '251-protein A bound to regions of the nitrocellulose paper corresponding to mf antigens of 1 12,000, 60,000, 45,000, and 25,000 M, and the loglo of serum dilutions ranging from 1:100 to 1 :10,000. Similar studies with pooled control serum led to lower levels of protein A binding (<300 cpm) that did not vary with the serum dilution.
Additional experiments were performed to examine whether live mf removed specific anti-mf antibodies from human sera. Individual serum samples (100 Ml) from four amicrofilaremic residents ofthe endemic area were incubated with I03 live B. malayi mf for 1 h at 37°C. The organisms were then removed by sedimentation and the antibody titer of the absorbed sample was measured and compared with results using a control aliquot of the same person's serum not exposed to mf.
Statistics. Student's t test was used to assess the significance of difference among various groups.
Results
Immunological identification offilarial antigens. Mice or rabbits immunized with mfextract developed serum anti-mf antibodies with an end titer of 1:5,000 by ELISA (results of testing eight different batches of sera). In 10 separate experiments, sera of both animal species contained IgG antibodies that bound consistently to four major mf antigens of 112,000, 60,000, 45,000, and 25,000 Mr (Fig. 1, A and B) . In contrast, sera of control mice and rabbits did not react with transblotted mf extract (Fig.  1, C and D) . There was no difference in these results when the mf extract was prepared in the presence or absence of protease inhibitors. Two-dimensional SDS-PAGE of mf extract showed multiple proteins with isoelectnrc point (pI) 4 (Fig. 2) . Sera ofage-matched control mice showed no reactivity with soluble mf extract transferred from the two-dimensional gel. Similar results were obtained with sera of mf-extract immunized and control rabbits.
To assess the stage-specificity of antigens detected with antimf antibodies, large amounts (60 Mg) of extracts of various parasite stages were subjected to SDS-PAGE, transferred to nitrocellulose paper, and incubated sequentially with a 1:20 dilution of immune or normal mouse serum and '25I-anti-mouse IgG. In addition, radioautographs were developed for 72 h rather than the usual 24 h to optimize detection of small amounts of antigen. Nonspecific binding of normal mouse serum to these parasite extracts was not observed. In contrast, immune mouse serum bound to four major mf antigens of 112,000, 60,000, 45,000, and 25,000 Mr (similar to those described in Fig. 1 (Fig. 3 D; female to male ratio of the preparation was 5:1) contained multiple antigens of similar apparent molecular weights, including molecules of 25,000-30,000 M,. Antigens with this relative molecular weight were not detectable in an equivalent amount of proteins extracted from sexually immature adult B. malayi (Fig. 3 C) .
Characterization ofprotective antigens. Two experiments to determine the ability of specific mf antigens to induce resistance in mice were performed. Data obtained in each were similar; results of one experiment are presented (Table I Characteristics ofhumanfilariasis study groups. Clinical and immunologic characteristics of the microfilaremic and amicrofilaremic residents of East Sepik Province are summarized in Table III . The mean age (32-37 yr) and disease manifestations (elephantiasis and hydroceles) attributable to chronic lymphatic obstruction were similar in both groups. The geometric mean end titers ofanti-mf antibody by solid-phase radioimmunoassay were 1:942 and 1:2,729 in the microfilaremic and amicrofilaremic groups, respectively. Microfilaremic individuals had a sig- Table IV . There were no significant differences in the geometric mean antibody titers to mf antigens of 112,000, 60,000, and 45,000 Mr (1:24-1:30 in microfilaremic individuals vs. 1:54-1:78 in amicrofilaremic individuals, P > 0.05). In contrast, the geometric mean antibody titer to the 25,000-Mr antigen was significantly higher (P < 0.025) in the amicrofilaremic group (1:424) than the microfilaremic group (1:95). In the group without detectable circulating mf, the serum antibody titer to this antigen was also greater than to the 112,000-, 60,000-, and 45,000-Mr antigens (P < 0.01). The relatively high antibody titer to the 25,000-Mr antigen in amicrofilaremic subjects was not reduced by preincubation oftheir sera with live mf. When sera of four of these subjects were exposed to an excess number of parasites (10,000/ml) before measurements of binding to the 25,000-Mr antigen, the antibody titers were 1:500, 1:1,000, 1:1,000, and 1:1,000. Values in aliquots of the same serum samples not preincubated with mf were 1 :100, 1: 1,000, 1: 100, and 1: 1,000, respectively. antimicrofilarial antibody titer § Geometric mean Gib 5.6±0.6 ¶ 3.1±0.6** 13 antigen index'1 * Number of individuals per group. t A 4-ml sample of blood was drawn between 2200 and 0200 h and microfilaremia determined by the nuclepore filtration method (23, 24) . When parasites on filters were too numerous to accurately count, a value of 1,000 mf per ml was assigned.
§ Anti-mf antibody titer to extracts of whole parasites were done by solid-phase radioimmunoassay in plastic wells as described in Methods. 11 A two-site radiometric assay utilizing Gib 13 monoclonal antibody was performed (28) . Values of .2.0 are considered to be positive for filarial infection (28) . T Mean±standard error. ** P < 0.05 vs. microfilaremic group.
Protective Antigens in Lymphatic Filariasis 1989 were determined by solid-phase radioimmunoassay using transblotted microfilarial antigens cut from strips of nitrocellulose paper and individual serum samples diluted 1:100-1:10,000 as described in Methods. Antibody titers of <1:100 were assigned a value of 1.000 for -loglo. § Actual number for reciprocal of geometric mean antibody titer.
Discussion
Our approach to identify protective filarial molecule(s) is to select first a series of candidate antigens on the basis of their ability to prevent development and/or enhance elimination ofblood-borne mfand adult worms in experimental animals. This was followed by documentation that antigen-induced resistance to one or several parasite stages is associated with and mediated by antibodies that recognize specific filarial antigens. The human antibody response to these specific filarial antigens was then evaluated in Papua New Guineans living in an area where Bancroftian filariasis is endemic. With the aim of establishing clinically and parasitologically meaningful correlates of this immunologic measurement, the antibody titers to these defined antigens were compared in groups of microfilaremic and amicrofilaremic individuals matched for age and disease status. These studies indicate that four major microfilarial antigens with 25,000-1 12,000 Mr react with IgG antibodies in sera of mice and rabbits immunized with mf extract. Mf molecules of 108,000-112,000 and 50,000-55,000 Mr also elicited antibody responses in occasional groups of immunized animals (2 of 10 groups ofCF1 mice in the current study). Inconsistent detection of this minor group of filarial antigens may be related to variability of the immune response in outbred animals and to the greater sensitivity of the Western blot technique when larger amounts of parasite extract are subjected to SDS-PAGE (e.g., 60 ,ug mf extract in Fig. 3 vs. 30 ,ig mf extract in Fig. 1 ). Experiments examining the parasite stage-specificity ofthe various mf antigens suggest that the 1 12,000-Mr molecule is shared by L3, immature adult worms, and sexually mature adult parasites.
In contrast, the -25,000-M. antigen is detectable in mf, L3, and mature adult worms but not in immature adult parasites. Competitive binding studies employing appropriate apparent molecular weight material extracted and purified from various stages of the parasite life cycle will be required to determine with certainty whether the -25,000-Mr antigen (or other mf antigens) are present in immature adult worms and shared by female and male parasites.
Immunogenic filarial molecules with -20,000-> 150,000 Mr have been described previously (32-37); however, their possible role in eliciting a host protective response is unknown. Immunization ofjirds with the mf antigen preparation described here has recently been shown to induce partial resistance to subcutaneous challenge with infective larvae (12), the natural route of infection in humans. This protective response (manifest by a >80% decrease in microfilaremia and 50% reduction in adult female worm burden) was associated with development of jird antibodies to antigens having apparent molecular weights similar to those recognized by mice and rabbits. In the present study, we compared the efficacy of the four major mf molecules in inducing resistance against microfilaremia in mice, experimental animals in which studies of antibody-dependent host clearance mechanisms directed exclusively against this stage of the parasite life cycle are possible (13, 22) . Whereas mice immunized with gel slices containing the 112,000-, 60,000-, or 45,000-Mr antigens did not have a significantly lower level of parasitemia compared with controls, recipients of the -25,000-M, antigen showed a 78-99% reduction in microfilaremia. This 25,000-Mr antigen appears to be distinct from that recently reported by Canlas and co-workers, who described a mouse IgG, monoclonal antibody that mediated transient depression of microfilaremia in jirds and recognized mf surface molecules of 75,000 and 70,000 Mr (38). Differences in the results ofthe present report and that ofCanlas et al. suggest that the method of sensitization used to produce antibodies for identification of protective antigens is selective for specific group(s) ofimmunogenic molecules. The monoclonal antibody which recognized antigens of 75,000 and 70,000 Mr was produced in mice injected intraperitoneally with live, intact mf, whereas the polyvalent serum used in the present study was obtained from animals immunized with soluble extracts of the organisms. The antibody response in the former case is likely to be restricted to molecules on the surface of intact mf while in the latter additional antigens may be exposed by the extraction procedure.
A major goal ofthese studies was to examine whether human antibody reactivity to the specific filarial antigens identified in experimental animals is related to the levels of parasitemia and worm burden in residents of an endemic area. Quantification of the intensity of infection in human lymphatic filariasis has been difficult and is a subject of controversy. To define, as accurately as possible, a study population homogenous for exposure to infective larvae, we examined individuals of known age who are life-long residents of a relatively isolated area of Papua New Guinea. Migration into and out of this region of East Sepik Province is minimal. The microfilarial carrier rate in various villages ranges from 68 to >80% (Forsyth, K. P., and J. W. Kazura, unpublished data; and 23). All individuals included in the study showed evidence of present or past exposure to lymphatic filariae. Their serum anti-mf antibody titers by solid-phase radioimmunoassay ranged from 1:250 to 1:10,000 compared with titers of less than 1:50 for Papua New Guineans who live in areas where Bancroftian filariasis is not transmitted. Age-and disease-matched study subjects were categorized into two groups according to the level of microfilaremia, currently the only direct method ofquantifying parasite burdens in humans. To maximize the reliability of distinguishing truly microfilaremic from amicrofilaremic subjects, larger than the usual diagnostic blood samples (4 ml) were drawn at the peak of parasitemia and were filtered by the nuclepore technique (25) . As an additional indirect measure of parasitologic status, the level of circulating Gib 13 antigen was quantified in a monoclonal antibody-based assay. The Gib 13 antibody is directed against an epitope contained in egg antigens of the filarial parasite Onchocerca gibsoni (26) . Increased amounts of cross-reacting antigens are present in the sera of W. bancrofti-infected subjects (27, 28) . In the current study, the mean Gib 13 level was significantly higher (P < 0.05) in microfilaremic subjects than in age-and disease-matched amicrofilaremic individuals. These data suggest that adult worm burdens may be greater in the group with parasitemia than in subjects without detectable circulating parasites. The use of the Gib 13 assay as an indirect index of total adult worm burden was supported by results of our in vitro studies ofepitope release. It was found that the epitope is released by immature and mature adult filariae of both sexes and that the amount of Gib 13 detectable in culture supernatants of live organisms is directly related to the number of parasites present. Investigations of in vivo metabolism of the Gib 13 epitope and the possible effects of immunologic (e.g., immune complex formation) and nonimmunologic factors (e.g., vascular distribution) on its detection in serum of experimentally infected hosts will be necessary, however, to confirm the utility of this serologic test in measurements of adult worm load. Direct examination and enumeration of adult worm burdens in humans is precluded by the inaccessibility of the parasites in the lymphatics.
We finally determined whether there was a correlation between the titer of human antibodies to the various apparent molecular weight antigens identified in the protection experiments and the parasitologic status ofthe individuals in the filariasis study population. There were no differences in the geometric mean antibody titers to filarial antigens of 1 12,000, 60,000, or 45,000 Mr for individuals with high levels of parasitemia (mean of 423 parasites per milliliter blood) versus those without circulating mf. In contrast, the mean antibody titer to the mfantigen of 25,000 Mr was significantly greater (P < 0.025) in the amicrofilaremic group than in the microfilaremic subjects. The relatively high antibody titer to the 25,000 Mr antigen in the amicrofilaremic subjects was not due to a lack of absorption of antibody by circulating parasites, as preincubation of these sera with live mffailed to reduce the level ofantibody binding. These data, in conjunction with in vivo protection experiments in mice, suggest that antibody responses to the 25,000-Mr antigen are an important determinant of host clearance of circulating mf. The reasons for the lower antibody titers to this specific antigen in the microfilaremic subjects are not known. Immunoregulatory processes that develop in the course of chronic infection, such as suppression of T and B cell responses to filarial antigens and development ofimmune complexes may, in part, be responsible (2-4, 39). In addition, it is possible that the isotype of antifilarial antibodies is affected (e.g., switch from IgG to IgE) by the level of parasitemia and repeated sensitization to filarial antigens (40) (41) (42) . Since serum studies do not distinguish between a lack of lymphoid cells that produce antibodies and removal of antibodies by antigens released into the bloodstream by mf destroyed in vivo, enumeration ofantigen-specific plaque-forming cells and their precursors will be an important step in evaluating further the possible utility of the 25,000-Mr or other antigens for a vaccine against human filariasis.
